{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:27:37Z","timestamp":1772782057527,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalimaging.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.clinimag.2018.09.010","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T12:06:43Z","timestamp":1537445203000},"page":"365-369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Clinical value of 99mTc-HYNIC-TOC SPECT\/CT for the diagnosis primary small cell neuroendocrine carcinomas of the nasal cavity and paranasal sinuses"],"prefix":"10.1016","volume":"52","author":[{"given":"Hong","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinimag.2018.09.010_bb0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12105-007-0004-7","article-title":"Non-small cell neuroendocrine carcinoma of the sinonasal tract and nasopharynx. Report of 2 cases and review of the literature","volume":"1","author":"Weinreb","year":"2007","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0010","series-title":"Small-Cell neuroendocrine carcinoma of nasopharynx: a case report","first-page":"1","volume":"vol. 3","author":"Bellahammou","year":"2017"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0015","first-page":"1","article-title":"Primary combined neuroendocrine and squamous cell carcinoma of the maxillary sinus: report of a case with Immunohistochemical and molecular characterization","volume":"9","author":"Franchi","year":"2013","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0020","doi-asserted-by":"crossref","DOI":"10.11604\/pamj.2017.27.82.10902","article-title":"Neuroendocrine carcinoma of the cervix: a case report and review of the literature","volume":"27","author":"Baggar","year":"2017","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0025","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1017\/S0022215112002435","article-title":"Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses: a rare case","volume":"126","author":"Tang","year":"2012","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0030","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4103\/jomfp.JOMFP_205_15","article-title":"Small cell neuroendocrine carcinoma of the paranasal sinus with intraoral involvement: report of a rare case and review of the literature","volume":"21","author":"Spadigam","year":"2017","journal-title":"J Oral Maxillofac Pathol"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.amjoto.2007.12.005","article-title":"Small cell neuroendocrine carcinoma of the ethmoid sinuses presenting with generalized seizure and syndrome of inappropriate antidiuretic hormone secretion: a case report and review of literature","volume":"30","author":"Ma","year":"2009","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0040","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00405-013-2554-5","article-title":"The importance of multimodality therapy in the treatment of sinonasal neuroendocrine carcinoma","volume":"270","author":"Tp","year":"2013","journal-title":"Eur Arch Oto-Rhino-Laryngology"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0045","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.2967\/jnumed.116.179234","article-title":"Molecular imaging of gastroenteropancreatic neuroendocrine tumors: current status and future directions","volume":"57","author":"Deroose","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0050","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.116.186361","article-title":"Current concepts in 68Ga-DOTATATE NEN imaging: interpretation, biodistribution, dosimetry and molecular strategies","author":"Bodei","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0055","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.2967\/jnumed.111.089276","article-title":"Treatment with octreotide does not reduce tumor uptake of (68)Ga-DOTATATE as measured by PET\/CT in patients with neuroendocrine tumors","volume":"52","author":"Haug","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0060","first-page":"1271","article-title":"Comparison of 68Ga-DOTATATE and 68Ga-DOTANOC PET\/CT imaging in the same patient group with neuroendocrine tumours","volume":"39","author":"Kabasakal","year":"2012","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0065","first-page":"728479","article-title":"Paranasal sinus neuroendocrine carcinoma: a case report and review of the literature","volume":"2013","author":"Sirsath","year":"2012","journal-title":"Case Rep Oncol Med"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0070","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/hed.10345","article-title":"Sinonasal neuroendocrine carcinoma in association with SIADH","volume":"26","author":"Vasan","year":"2004","journal-title":"Head Neck"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0075","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/1097-0142(19800115)45:2<330::AID-CNCR2820450222>3.0.CO;2-S","article-title":"Neuroendocrine carcinoma of the paranasal sinus: a morphological and endocrinological study","volume":"45","author":"Kameya","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0080","doi-asserted-by":"crossref","first-page":"5775","DOI":"10.7314\/APJCP.2013.14.10.5775","article-title":"Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine tumors: analysis from a single-institution","volume":"14","author":"Zeng","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0085","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1026270","article-title":"Molecular imaging of cancer with nanoparticle-based theranostic probes","volume":"2017","author":"Ma","year":"2017","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0090","article-title":"Background, current role, and potential applications of radiogenomics","author":"Pinker","year":"2017","journal-title":"J Magn Reson Imaging"},{"issue":"Suppl. 2","key":"10.1016\/j.clinimag.2018.09.010_bb0095","doi-asserted-by":"crossref","first-page":"42S","DOI":"10.2967\/jnumed.110.085753","article-title":"Radiopeptide imaging and therapy in Europe","volume":"52","author":"Ambrosini","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0100","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5603\/NMR.2016.0018","article-title":"Influence of PET\/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA\/HYNIC-TOC SPECT","volume":"19","author":"Madrzak","year":"2016","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0105","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3892\/ol.2013.1435","article-title":"Somatostatin receptor subtypes 2 and 5 are associated with better survival in operable hepatitis B-related hepatocellular carcinoma following octreotide long-acting release treatment","volume":"6","author":"Yao","year":"2013","journal-title":"Oncol Lett"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0110","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1148\/rg.352140164","article-title":"Somatostatin receptor imaging with 68Ga DOTATATE PET\/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation","volume":"35","author":"Hofman","year":"2015","journal-title":"Radiographics"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0115","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5603\/NMR.2016.0024","article-title":"Radiopharmaceuticals for somatostatin receptor imaging","volume":"19","author":"Miko\u0142ajczak","year":"2016","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0120","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1002\/cncr.10537","article-title":"Neuroendocrine tumors of the sinonasal tract. Results of a prospective study incorporating chemotherapy, surgery, and combined proton-photon radiotherapy","volume":"94","author":"Fitzek","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0125","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1017\/S0022215106000594","article-title":"Small cell neuroendocrine carcinoma of the nasal cavity and paranasal sinuses","volume":"120","author":"Babin","year":"2006","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1758-3284-3-32","article-title":"Sinonasal neuroendocrine carcinoma: impact of differentiation status on response and outcome","volume":"3","author":"Likhacheva","year":"2011","journal-title":"Head Neck Oncol"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0135","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3109\/00016480903148274","article-title":"Sino-nasal neuro-endocrine carcinoma","volume":"130","author":"Chang","year":"2010","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0140","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.118.209841","article-title":"Safety, pharmacokinetics and dosimetry of a long-acting radiolabeled somatostatin analogue (177)Lu-DOTA-EB-TATE in patients with advanced metastatic neuroendocrine tumors","author":"Zhang","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0145","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.clinimag.2011.11.005","article-title":"Are RECIST criteria sufficient to assess response to therapy in neuroendocrine tumors?","volume":"36","author":"Sowa-Staszczak","year":"2012","journal-title":"Clin Imaging"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0150","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1007\/s00259-013-2501-0","article-title":"Gratifying clinical experience with an indigenously formulated; single-vial lyophilized HYNIC-TOC kit at the radiopharmaceutical; division of BARC: a pivotal boost for building up a peptide receptor; radionuclide therapy programme in an Indian setting","volume":"40","author":"Basu","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.clinimag.2018.09.010_bb0155","doi-asserted-by":"crossref","DOI":"10.1186\/s40658-017-0191-6","article-title":"Patient-specific dosimetry of (99m)Tc-HYNIC-Tyr(3)-octreotide in children","volume":"4","author":"Hou","year":"2017","journal-title":"EJNMMI Phys"}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707118302493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707118302493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T17:25:04Z","timestamp":1544203504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899707118302493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":31,"alternative-id":["S0899707118302493"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2018.09.010","relation":{},"ISSN":["0899-7071"],"issn-type":[{"value":"0899-7071","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical value of 99mTc-HYNIC-TOC SPECT\/CT for the diagnosis primary small cell neuroendocrine carcinomas of the nasal cavity and paranasal sinuses","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2018.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}